gadobutrol and its Impurities

Gadobutrol is a gadolinium-based MRI contrast agent. It is used to help diagnose certain disorders of the brain and spine, the blood vessels of the kidneys, and the heart. Reference standards of Gadobutrol API,and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.

Displaying 16 results for gadobutrol Impurities
Drug Reference Standards & Impurity Synthesis in India
PA 07 61000

Gadobutrol

Gadobutrol


  • Catalogue No.:PA 07 61000

  • CAS :

    770691-21-9

  • Molecular Formula : C18H31GdN4O9

  • Molecular Weight : 604.71

Drug Reference Standards & Impurity Synthesis in India
PA EPY0001803

Gadobutrol monohydrate (Y0001803)

Gadobutrol monohydrate (Y0001803)


  • Catalogue No.:PA EPY0001803

  • CAS :

    NA

  • Molecular Formula : NA

  • Molecular Weight : NA

Drug Reference Standards & Impurity Synthesis in India
PA EPY0001804

Gadobutrol for peak identification (Y0001804)

Gadobutrol for peak identification (Y0001804)


  • Catalogue No.:PA EPY0001804

  • CAS :

    NA

  • Molecular Formula : NA

  • Molecular Weight : NA

Drug Reference Standards & Impurity Synthesis in India
PA 07 0611000

Gadobutrol System Suitability Mixture

Gadobutrol System Suitability Mixture


  • Catalogue No.:PA 07 0611000

  • CAS :

    NA

  • Molecular Formula : NA

  • Molecular Weight : NA

Drug Reference Standards & Impurity Synthesis in India
PA 07 0611001

rel-(5R,6S)-6-(1,4,7,10-Tetraazacyclododecan-1-yl)-2,2-dimethyl-1,3-dioxepan-5-ol

rel-(5R,6S)-6-(1,4,7,10-Tetraazacyclododecan-1-yl)-2,2-dimethyl-1,3-dioxepan-5-ol


  • Catalogue No.:PA 07 0611001

  • CAS :

    198637-63-7

  • Molecular Formula : C15H32N4O3

  • Molecular Weight : 316.45

Drug Reference Standards & Impurity Synthesis in India
PA 07 0611002

N,N′,N′′-Tritosyldiethylenetriamine

N,N′,N′′-Tritosyldiethylenetriamine


  • Catalogue No.:PA 07 0611002

  • CAS :

    56187-04-3

  • Molecular Formula : C25H31N3O6S3

  • Molecular Weight : 565.72

Drug Reference Standards & Impurity Synthesis in India
PA 07 0611003

3,6,9-Tritosyl-3,6,9-triaza-1(2,6)-pyridinacyclodecaphane

3,6,9-Tritosyl-3,6,9-triaza-1(2,6)-pyridinacyclodecaphane


  • Catalogue No.:PA 07 0611003

  • CAS :

    78668-28-7

  • Molecular Formula : C32H36N4O6S3

  • Molecular Weight : 668.84

Drug Reference Standards & Impurity Synthesis in India
PA 07 0611004

Calcobutrol

Calcobutrol


  • Catalogue No.:PA 07 0611004

  • CAS :

    151878-23-8

  • Molecular Formula : C18H32CaN4O9

  • Molecular Weight : 488.55

Drug Reference Standards & Impurity Synthesis in India
PA 07 0611005

1,2,2a1,3,4,6,7,8-Octahydro-5H-2a,4a,6a,8a-tetraazacyclopenta[fg]acenaphthylen-6a-ium Bromide

1,2,2a1,3,4,6,7,8-Octahydro-5H-2a,4a,6a,8a-tetraazacyclopenta[fg]acenaphthylen-6a-ium Bromide


  • Catalogue No.:PA 07 0611005

  • CAS :

    186546-54-3

  • Molecular Formula : C10H17BrN4

  • Molecular Weight : 273.18

Drug Reference Standards & Impurity Synthesis in India
PA 07 0611006

DOTA-NHS-ester Hexafluorophosphate TFA Salt

DOTA-NHS-ester Hexafluorophosphate TFA Salt


  • Catalogue No.:PA 07 0611006

  • CAS :

    1823122-52-6

  • Molecular Formula : C22H33F9N5O12P

  • Molecular Weight : 761.49

Drug Reference Standards & Impurity Synthesis in India
PA 07 0611007

DOTA-Tris(tBu)

DOTA-Tris(tBu)


  • Catalogue No.:PA 07 0611007

  • CAS :

    137076-54-1

  • Molecular Formula : C28H52N4O8

  • Molecular Weight : 572.74

Drug Reference Standards & Impurity Synthesis in India
PA 07 0611008

1,4,7-Tribenzyl-1,4,7,10-tetraazacyclododecane

1,4,7-Tribenzyl-1,4,7,10-tetraazacyclododecane


  • Catalogue No.:PA 07 0611008

  • CAS :

    183160-82-9

  • Molecular Formula : C29H38N4

  • Molecular Weight : 442.65

Drug Reference Standards & Impurity Synthesis in India
PA 07 0611009

1,4-Dibenzyl-1,4,7,10-tetraazacyclododecane

1,4-Dibenzyl-1,4,7,10-tetraazacyclododecane


  • Catalogue No.:PA 07 0611009

  • CAS :

    216101-03-0

  • Molecular Formula : C22H32N4

  • Molecular Weight : 352.53

Drug Reference Standards & Impurity Synthesis in India
PA 07 0611010

2a1,5a-Dimethyloctahydro-3H,6H-2a,5,6,8a-tetraazaacenaphthylene

2a1,5a-Dimethyloctahydro-3H,6H-2a,5,6,8a-tetraazaacenaphthylene


  • Catalogue No.:PA 07 0611010

  • CAS :

    1822607-61-3

  • Molecular Formula : C10H20N4

  • Molecular Weight : 196.3

Drug Reference Standards & Impurity Synthesis in India
PA 07 0611011

1,7-Dinitroso-1,4,7,10-tetraazacyclododecane

1,7-Dinitroso-1,4,7,10-tetraazacyclododecane


  • Catalogue No.:PA 07 0611011

  • CAS :

    NA

  • Molecular Formula : C8H18N6O2

  • Molecular Weight : 230.27

Drug Reference Standards & Impurity Synthesis in India
PA 07 0611012

4,7-Bis(6-hydroxy-2,2-dimethyl-1,3-dioxepan-5-yl)-1,4,7,10-tetraazacyclododecane-1-carbaldehyde

4,7-Bis(6-hydroxy-2,2-dimethyl-1,3-dioxepan-5-yl)-1,4,7,10-tetraazacyclododecane-1-carbaldehyde


  • Catalogue No.:PA 07 0611012

  • CAS :

    NA

  • Molecular Formula : C23H44N4O7

  • Molecular Weight : 488.63

pharmaffiliates